We are live on ! Find out more
PHS

PFM Health Sciences Portfolio holdings

AUM $1.1B
1-Year Est. Return 57.92%
This Fund
S&P 500
This Quarter Est. Return
+12.45%
1 Year Est. Return
+57.92%
3 Year Est. Return
+183.93%
5 Year Est. Return
+283%
10 Year Est. Return
+2,507.28%
AUM
$1.3B
AUM Growth
+$126M
Cap. Flow
+$12.8M
Cap. Flow %
0.98%
Top 10 Hldgs %
49.24%
Holding
85
New
28
Increased
16
Reduced
23
Closed
13

Top Buys

Rank Stock Value
1
UHS icon
Universal Health Services
UHS
+$20.9M
2
ADMA icon
ADMA Biologics
ADMA
+$20.2M
3
UTHR icon
United Therapeutics
UTHR
+$19.9M
4
MRK icon
Merck
MRK
+$19.5M
5
ELV icon
Elevance Health
ELV
+$18.9M

Top Sells

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$31.9M
2
DHR icon
Danaher
DHR
+$31.9M
3
HUM icon
Humana
HUM
+$27.8M
4
MOH icon
Molina Healthcare
MOH
+$25.5M
5
ALNY icon
Alnylam Pharmaceuticals
ALNY
+$23.6M

Sector Composition

Rank Sector Weight
1 Healthcare 87.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LLY icon
1
Eli Lilly
LLY
$1.04T
$172M 13.21%
225,139
-42,884
-16% -$31.9M
THC icon
2
Tenet Healthcare
THC
$16.8B
$93.7M 7.21%
461,654
-37,589
-8% -$6.67M
XBI icon
3
CALL
State Street SPDR S&P Biotech ETF
XBI
$10.2B
$71.9M 5.53%
+717,400
New +$64.6M
AXSM icon
4
Axsome Therapeutics
AXSM
$12.3B
$64.4M 4.95%
530,332
+47,227
+10% +$5.32M
MCK icon
5
McKesson
MCK
$95.3B
$55.9M 4.3%
72,313
– –
PEN icon
6
Penumbra
PEN
$12.4B
$49.4M 3.8%
195,085
+28,824
+17% +$7.27M
UTHR icon
7
United Therapeutics
UTHR
$26.2B
$40.1M 3.08%
95,650
+59,259
+163% +$19.9M
ISRG icon
8
Intuitive Surgical
ISRG
$121B
$34.6M 2.66%
77,403
-11,564
-13% -$5.55M
EW icon
9
Edwards Lifesciences
EW
$48.6B
$29.7M 2.28%
381,324
-11,179
-3% -$873K
ASND icon
10
Ascendis Pharma A/S
ASND
$16.5B
$28.9M 2.22%
145,311
-76,443
-34% -$14.3M
HUM icon
11
CALL
Humana
HUM
$47.7B
$28.6M 2.2%
+110,000
New +$28.9M
HCA icon
12
HCA Healthcare
HCA
$82.5B
$28M 2.16%
65,773
-6,517
-9% -$2.53M
CVS icon
13
CVS Health
CVS
$138B
$26.1M 2.01%
346,679
-132,326
-28% -$9.07M
COR icon
14
Cencora
COR
$58.5B
$25.2M 1.93%
80,493
+27,206
+51% +$8.01M
OM icon
15
Outset Medical
OM
$76.6M
$24.4M 1.88%
1,729,921
+65,194
+4% +$1.02M
UHS icon
16
Universal Health Services
UHS
$9.04B
$23.8M 1.83%
+116,260
New +$20.9M
ICLR icon
17
Icon
ICLR
$12.9B
$23.4M 1.8%
133,683
+45,502
+52% +$7.62M
CNC icon
18
Centene
CNC
$32.5B
$20.5M 1.58%
+574,360
New +$17.3M
MRK icon
19
Merck
MRK
$315B
$19.8M 1.53%
+236,468
New +$19.5M
ELV icon
20
Elevance Health
ELV
$84.4B
$19.6M 1.51%
+60,776
New +$18.9M
NTRA icon
21
Natera
NTRA
$37.8B
$18.6M 1.43%
115,596
+14,346
+14% +$2.27M
ADMA icon
22
ADMA Biologics
ADMA
$1.94B
$17.3M 1.33%
+1,181,011
New +$20.2M
NEO icon
23
NeoGenomics
NEO
$1.82B
$17M 1.31%
2,208,530
+1,438,492
+187% +$10.1M
BBIO icon
24
BridgeBio Pharma
BBIO
$16.2B
$17M 1.31%
327,174
-194,619
-37% -$9.49M
SLNO
25
DELISTED
Soleno Therapeutics
SLNO
$16.5M 1.27%
243,401
-163,801
-40% -$12.1M
1
2 3 4

Similar funds

DAM
Delta Asset Management Memphis, Tennessee $1.1B AUM 14.89% 1-Year Est. Return
MAM
Mark Asset Management New York $1.1B AUM 43.79% 1-Year Est. Return
CPRC
Consolidated Portfolio Review Corp Woodbury, New York $1.1B AUM 8.96% 1-Year Est. Return
LCM
Legato Capital Management San Francisco, California $1.1B AUM 61.65% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.1B AUM 30.57% 1-Year Est. Return
DAM
DLD Asset Management New York $1.1B AUM 4.68% 1-Year Est. Return
KCM
Khrom Capital Management Miami Beach, Florida $1.09B AUM 14.82% 1-Year Est. Return
CF
Corebridge Financial Houston, Texas $1.09B AUM 1.85% 1-Year Est. Return

PFM Health Sciences's Q3 2025 Portfolio in Review

As of Q3 2025, PFM Health Sciences held 85 positions worth $1.3B, up 11% from $1.17B the previous quarter. Its ten largest holdings account for 49% of the portfolio.

PFM Health Sciences's Q3 2025 filing shows 28 new, 16 increased, 23 reduced and 13 closed positions. Its largest new stake was Universal Health Services: 116,260 shares worth $23.8M. The largest sale was Eli Lilly, an estimated $31.9M.

By sector, the portfolio is most concentrated in Healthcare at 88% of assets, down from 95% a quarter earlier.

  • PFM Health Sciences's largest Q3 2025 buy was Universal Health Services: 116,260 shares worth $23.8M.
  • PFM Health Sciences added most to United Therapeutics in Q3 2025, an estimated $19.9M increase.
  • PFM Health Sciences's biggest Q3 2025 reduction was Eli Lilly, cutting an estimated $31.9M.
  • PFM Health Sciences fully exited Danaher in Q3 2025, selling an estimated $31.9M.
  • PFM Health Sciences's ten largest holdings make up 49% of its $1.3B portfolio in Q3 2025.
  • PFM Health Sciences opened 28 new positions and closed 13 in Q3 2025.
  • PFM Health Sciences's portfolio value rose 11% quarter-over-quarter to $1.3B.

Based on PFM Health Sciences's 13F filing for Q3 2025, filed 14 Nov 2025.